Human PPARG/NR1C3/PPARG1 ORF/cDNA clone-Lentivirus plasmid (BC006811)

Cat. No.: pGMLP-SPh-126
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human PPARG/NR1C3/PPARG1 Lentiviral expression plasmid for PPARG lentivirus packaging, PPARG lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to PPAR Gamma/PPARG/PPAR-gamma/PPARG/NR1C3 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $701.52
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP-SPh-126
Gene Name PPARG
Accession Number BC006811
Gene ID 5468
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 1434 bp
Gene Alias NR1C3,PPARG1,PPARG2
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGACCATGGTTGACACAGAGATGCCATTCTGGCCCACCAACTTTGGGATCAGCTCCGTGGATCTCTCCGTAATGGAAGACCACTCCCACTCCTTTGATATCAAGCCCTTCACTACTGTTGACTTCTCCAGCATTTCTACTCCACATTACGAAGACATTCCATTCACAAGAACAGATCCAGTGGTTGCAGATTACAAGTATGACCTGAAACTTCAAGAGTACCAAAGTGCAATCAAAGTGGAGCCTGCATCTCCACCTTATTATTCTGAGAAGACTCAGCTCTACAATAAGCCTCATGAAGAGCCTTCCAACTCCCTCATGGCAATTGAATGTCGTGTCTGTGGAGATAAAGCTTCTGGATTTCACTATGGAGTTCATGCTTGTGAAGGATGCAAGGGTTTCTTCCGGAGAACAATCAGATTGAAGCTTATCTATGACAGATGTGATCTTAACTGTCGGATCCACAAAAAAAGTAGAAATAAATGTCAGTACTGTCGGTTTCAGAAATGCCTTGCAGTGGGGATGTCTCATAATGCCATCAGGTTTGGGCGGATGCCACAGGCCGAGAAGGAGAAGCTGTTGGCGGAGATCTCCAGTGATATCGACCAGCTGAATCCAGAGTCCGCTGACCTCCGGGCCCTGGCAAAACATTTGTATGACTCATACATAAAGTCCTTCCCGCTGACCAAAGCAAAGGCGAGGGCGATCTTGACAGGAAAGACAACAGACAAATCACCATTCGTTATCTATGACATGAATTCCTTAATGATGGGAGAAGATAAAATCAAGTTCAAACACATCACCCCCCTGCAGGAGCAGAGCAAAGAGGTGGCCATCCGCATCTTTCAGGGCTGCCAGTTTCGCTCCGTGGAGGCTGTGCAGGAGATCACAGAGTATGCCAAAAGCATTCCTGGTTTTGTAAATCTTGACTTGAACGACCAAGTAACTCTCCTCAAATATGGAGTCCACGAGATCATTTACACAATGCTGGCCTCCTTGATGAATAAAGATGGGGTTCTCATATCCGAGGGCCAAGGCTTCATGACAAGGGAGTTTCTAAAGAGCCTGCGAAAGCCTTTTGGTGACTTTATGGAGCCCAAGTTTGAGTTTGCTGTGAAGTTCAATGCACTGGAATTAGATGACAGCGACTTGGCAATATTTATTGCTGTCATTATTCTCAGTGGAGACCGCCCAGGTTTGCTGAATGTGAAGCCCATTGAAGACATTCAAGACAACCTGCTACAAGCCCTGGAGCTCCAGCTGAAGCTGAACCACCCTGAGTCCTCACAGCTGTTTGCCAAGCTGCTCCAGAAAATGACAGACCTCAGACAGATTGTCACGGAACACGTGCAGCTACTGCAGGTGATCAAGAAGACGGAGACAGACATGAGTCTTCACCCGCTCCTGCAGGAGATCTACAAGGACTTGTACTAG
ORF Protein Sequence MTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T58921-Ab Anti-PPAR-gamma monoclonal antibody
    Target Antigen GM-Tg-g-T58921-Ag PPAR-gamma/PPARG protein
    ORF Viral Vector pGMAD000274 Human PPARG Adenovirus plasmid
    ORF Viral Vector pGMAD000670 Human PPARG Adenovirus plasmid
    ORF Viral Vector pGMAP000222 Human PPARG Adenovirus plasmid
    ORF Viral Vector pGMLP-SPh-126 Human PPARG Lentivirus plasmid
    ORF Viral Vector pGMAP-SPh-266 Human PPARG Adenovirus plasmid
    ORF Viral Vector pGMPC000104 Human PPARG Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector pGMPC000794 Human PPARG Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector pGMPC000893 Human PPARG Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector vGMAD000274 Human PPARG Adenovirus particle
    ORF Viral Vector vGMAD000670 Human PPARG Adenovirus particle
    ORF Viral Vector vGMAP000222 Human PPARG Adenovirus particle
    ORF Viral Vector vGMLP-SPh-126 Human PPARG Lentivirus particle
    ORF Viral Vector vGMAP-SPh-266 Human PPARG Adenovirus particle


    Target information

    Target ID GM-T58921
    Target Name PPAR Gamma/PPARG/PPAR-gamma
    Gene Group Identifier
    （Target Gene ID in Homo species)         		5468
    Gene ID 100051258 (Equus caballus), 101095161 (Felis catus), 19016 (Mus musculus), 25664 (Rattus norvegicus)
    281993 (Bos taurus), 403606 (Canis lupus familiaris), 5468 (Homo sapiens), 574190 (Macaca mulatta)
    Gene Symbols & Synonyms PPARG,Pparg,Nr1c3,PPARgamma,PPAR-gamma,PPARgamma2,PPAR-gamma2,PPAR-GAMMA,GLM1,CIMT1,FPLD3,NR1C3,PPARG1,PPARG2,PPARG5,PPARGAMMA
    Target Alternative Names CIMT1,FPLD3,GLM1,NR1C3,Nr1c3,Nuclear receptor subfamily 1 group C member 3,PPAR Gamma,PPAR-GAMMA,PPAR-gamma,PPAR-gamma2,PPARG,PPARG1,PPARG2,PPARG5,PPARGAMMA,PPARgamma,PPARgamma2,Peroxisome proliferator-activated receptor gamma,Pparg
    Uniprot Accession O18924,O18971,O88275,P37231,P37238,Q4U3Q4
    Additional SwissProt Accessions: P37238,O88275,O18971,Q4U3Q4,P37231,O18924
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category Therapeutics Target
    Disease cancer
    Disease from KEGG PPAR signaling pathway, Longevity regulating pathway, Osteoclast differentiation, Pathways in cancer, Thyroid cancer, Lipid and atherosclerosis
    Gene Ensembl ENSECAG00000016664, ENSMUSG00000000440, ENSCAFG00845029007, ENSG00000132170, ENSMMUG00000007191
    Target Classification Nuclear Receptors, Tumor-associated antigen (TAA)


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.